SCHEMBL30978697

SCHEMBL30978697

CSc1cccc(C)c1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.39
▸ CYP2A6 P11509 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ MAPT P10636 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ HCAR1 Q9BXC0 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TRPA1 O75762 2/20 0.31
▸ CD44 P16070 1/20 0.31
▸ GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30978699 1.00 ALDH1A1 (0.39) ALDH1A1CYP2A6CYP1A2LMNATSHR
SCHEMBL16951365 1.00 ALDH1A1 (0.39) ALDH1A1CYP2A6CYP1A2LMNATSHR
SCHEMBL943710 0.83 ALDH1A1 (0.40) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL28619325 0.78 ALDH1A1 (0.32) ALDH1A1TSHR
SCHEMBL8164803 0.76 ALDH1A1 (0.53) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL62013 0.76 — —
SCHEMBL30367649 0.75 TRPA1 (0.44) ALDH1A1CYP2A6CYP1A2LMNATSHR
SCHEMBL700366 0.75 TRPA1 (0.44) ALDH1A1CYP2A6CYP1A2LMNATSHR
SCHEMBL2563157 0.74 LMNA (0.36) ALDH1A1LMNATSHRCA1CA2
SCHEMBL29928431 0.74 MAPT (0.42) ALDH1A1CYP2A6CYP1A2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118373783-A Method for preparing topramezone intermediate dihydro-isoxazole compound 帕潘纳(北京)科技有限公司 2024-07-23 — — CN disclosed
Send feedback